Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Vaccines, Blood & Biologics

08/25/ 2008 Email - RiaSTAP

From: Kumar, Vasantha

Sent: Monday, August 25, 2008 12:04 PM

To: ''

Subject: STN.125317/0.CSL Behring. Human Fibrinogen Concentrate, Pasteurized. Riastap

Importance: High

Hi David,

The reviewer for labeling portion of the BLA would like you to provide the "Rationale for Choice of Proprietary Name".

She mentioned that a review of the study report does not include the rationale for choice of the name, RIASTAP.

So, could you please provide that to us? If you think it is already included in one of the modules, could you please specify the location?



Vasantha Kumar, M.S., Ph.D.
Room 485N/HFM-380
1401 Rockville Pike
Rockville, MD 20852
Phone: 301-827-3524
Fax: 301-827-2857

Page Last Updated: 06/02/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English